- ►utas.edu.au [PDF] RW Nesto - Clinical Diabetes, 2008 - Am Diabetes Assoc Managing the high risk for cardiovascular morbidity and mortality in diabetic
patients is a challenge for practicing clinicians. Reducing the burden of
cardiovascular disease in diabetes should begin with assessment and ... Cited by 3 - Related articles - BL Direct - All 7 versions
H Bays, PH Jones - Vascular Health and Risk Management, 2007 - pubmedcentral.nih.gov Colesevelam HCl is a bile acid sequestrant (BAS) which has been specifically
designed with a unique structure for the purpose of improving tolerability and
reducing potential drug interactions compared to older BAS, such as ... Cited by 4 - Related articles - BL Direct - All 6 versions
- ►nursing2008.com J Hartweg, AJ Farmer, RR Holman, A Neil - Current Opinion in Lipidology, 2009 - journals.lww.com Introduction This systematic review pools data from previously ident- ified
trials and seven new cardiovascular disease (CVD) prevention trials published
during 2007–2008 for patients with type 2 diabetes given marine-derived ... Cited by 7 - Related articles - All 5 versions
[CITATION] Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Determinants of new-onset …
DL Simel - Am J Manag Care, 2007 - ajmc.com The leading cause of death in the United States is coronary heart disease. Among
patients at the greatest risk of death from heart disease, medical interventions
that reduce low- density lipoprotein cholesterol (LDL-C) have repeatedly ... Cited by 7 - Related articles - View as HTML - BL Direct - All 3 versions
[CITATION] Screening, diagnosis, and management of diabetes-related complications
M Peeples, JJ Seley - AJN The American Journal of Nursing, 2007 - journals.lww.com Diabetes is epidemic in the United States: in 2005, 20.8 million people had
either type 1 or type 2 diabetes,1 and 39 million are projected to have the
disease by 2050.2 More therapies than ever are available to treat diabetes, ... Cited by 2 - Related articles - All 3 versions
Y Ousman, M Sharma - Clinical Diabetes, 2001 - Am Diabetes Assoc Outcomes measured. Primary predefined aggregate clinical outcomes: any end point
or death related to diabetes and all-cause mortality. Secondary aggregate
outcomes: myocardial infarction (MI), cerebrovascular accident, amputation, ... Cited by 2 - Related articles - All 2 versions
[CITATION] Tip 2 Diabetes mellitus ve koroner arter hastalığı
- ►dvdres.com [PDF] JC Fruchart, FM Sacks, MP Hermans, G … - Diabetes & Vascular Disease Research, 2008 - dvr.sagepub.com DOI: 10.3132/dvdr.2008.046 2008; 5; 319 Diab Vasc Dis Res Zambon and Paul Zimmet ... Jorge Plutzky, Zeljko Reiner, Robert S Rosenson, Bart Staels, Jane K Stock,
Rody Sy, Christoph Wanner, Alberto Chapman, Paul M Dodson, Paola Fioretto, ... Cited by 10 - Related articles - All 11 versions
